166 related articles for article (PubMed ID: 24533890)
1. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
Trials; 2014 Feb; 15():60. PubMed ID: 24533890
[TBL] [Abstract][Full Text] [Related]
2. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
[TBL] [Abstract][Full Text] [Related]
3. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF
Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302
[TBL] [Abstract][Full Text] [Related]
4. Glycopyrrolate for chronic drooling in children.
Eiland LS
Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic medications for reducing drooling in children with developmental disability.
Reid SM; Westbury C; Guzys AT; Reddihough DS
Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
[TBL] [Abstract][Full Text] [Related]
6. Glycopyrronium for severe drooling in children.
Drug Ther Bull; 2017 Aug; 55(8):93-96. PubMed ID: 28808084
[TBL] [Abstract][Full Text] [Related]
7. Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial.
Fayoux P; Dinomais M; Shaw H; Villain F; Schwartz D; Rondeau S; Letellier G; Auvin S
Dev Med Child Neurol; 2024 Jul; 66(7):910-918. PubMed ID: 38214675
[TBL] [Abstract][Full Text] [Related]
8. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
9. Glycopyrrolate for drooling in children with medical complexity under three years of age.
Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
[TBL] [Abstract][Full Text] [Related]
10. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
[TBL] [Abstract][Full Text] [Related]
11. Interventions for drooling in children with cerebral palsy.
Walshe M; Smith M; Pennington L
Cochrane Database Syst Rev; 2012 Feb; (2):CD008624. PubMed ID: 22336850
[TBL] [Abstract][Full Text] [Related]
12. Management of drooling in children: a survey of UK paediatricians' clinical practice.
Parr JR; Buswell CA; Banerjee K; Fairhurst C; Williams J; O'Hare A; Pennington L;
Child Care Health Dev; 2012 Mar; 38(2):287-91. PubMed ID: 21392056
[TBL] [Abstract][Full Text] [Related]
13. Glycopyrrolate treatment of chronic drooling.
Blasco PA; Stansbury JC
Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
[TBL] [Abstract][Full Text] [Related]
14. Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.
Fayoux P; Dinomais M; Shaw H; Probert N; Villain F; Pouchain D; Texier N; Auvin S
BMJ Paediatr Open; 2023 May; 7(1):. PubMed ID: 37156563
[TBL] [Abstract][Full Text] [Related]
15. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital.
Al Jeraisy M; AlFuraih M; AlSaif R; AlKhalifah B; AlOtaibi H; Abolfotouh MA
BMC Pediatr; 2020 Sep; 20(1):437. PubMed ID: 32943036
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Visual side-effects from transdermal scopolamine (hyoscine).
Firth AY; Walker K
Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
[TBL] [Abstract][Full Text] [Related]
19. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
[TBL] [Abstract][Full Text] [Related]
20. Interventions for drooling in children with cerebral palsy.
Walshe M; Smith M; Pennington L
Cochrane Database Syst Rev; 2012 Nov; 11():CD008624. PubMed ID: 23152263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]